Labcorp director sells $954K in stock under plan

LABCORP HOLDINGS INC. director Kerrii B. Anderson reported selling 3,000 shares of common stock on 2026-08-17 at $318.02 per share in an open-market or private transaction made pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. director Kerrii B. Anderson reported selling 3,000 shares of common stock on 2026-08-17 at $318.02 per share in an open-market or private transaction made pursuant to a Rule 10b5-1 trading plan. After this sale, she held 6,563 shares directly and 144 shares indirectly in each of two separate trusts.

Insider Trade Summary 10b5-1

Net Seller: 3,000 shares

Net Sell 3 txns

Insider ANDERSON KERRII B

Role Director

Sold 3,000 shs ($954K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	3,000	$318.02	$954K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 6,563 shares (Direct); Common Stock — 144 shares (Indirect, By Alexa M. Anderson Separate Trust); Common Stock — 144 shares (Indirect, By Cameron Taff Anderson Separate Trust)

Footnotes (1)

1. F1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Key Figures

Shares sold: 3,000 shares Sale price per share: $318.02 per share Approximate transaction value: $954,060 +2 more

5 metrics

Shares sold 3,000 shares Common Stock sold on 2026-08-17 by Kerrii B. Anderson

Sale price per share $318.02 per share Price for the 3,000-share sale of Common Stock

Approximate transaction value $954,060 3,000 shares sold at $318.02 per share

Direct holdings after transaction 6,563 shares Common Stock directly owned by Kerrii B. Anderson after the sale

Indirect holdings per trust 144 shares Common Stock held in each of two separate trusts

Key Terms

Rule 10b5-1, open market or private transaction, Separate Trust

3 terms

Rule 10b5-1 regulatory

"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

Separate Trust financial

"nature_of_ownership: By Alexa M. Anderson Separate Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kerrii B. Anderson report for LABCORP HOLDINGS INC. (LH)?

Kerrii B. Anderson reported selling 3,000 shares of Labcorp common stock on 2026-08-17 at $318.02 per share. The sale was coded as an open-market or private transaction and reported on a Form 4 insider filing.

Was Kerrii B. Anderson’s sale of LABCORP (LH) stock under a Rule 10b5-1 plan?

Yes. The filing states the 3,000-share sale was made pursuant to a Rule 10b5-1 trading plan under the Securities Exchange Act of 1934. This indicates the trades followed a pre-established, pre-disclosed plan.

How many LABCORP (LH) shares does Kerrii B. Anderson hold after this Form 4 sale?

After the reported transaction, Kerrii B. Anderson held 6,563 shares of Labcorp common stock directly. She also had 144 shares held indirectly in each of two separate trusts, as disclosed in the Form 4 holding entries.

What was the total dollar value of Kerrii B. Anderson’s LABCORP (LH) stock sale?

Based on 3,000 shares sold at $318.02 per share, the transaction value is approximately $954,060. This figure comes from multiplying the reported share count by the reported per-share sale price.

How are Kerrii B. Anderson’s indirect LABCORP (LH) holdings structured?

The Form 4 lists indirect ownership of 144 shares of Labcorp common stock in the Alexa M. Anderson Separate Trust and 144 shares in the Cameron Taff Anderson Separate Trust, both reported as indirect holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 08:10 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDERSON KERRII B

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/17/2026		S(1)		3,000	D	$318.02	6,563	D
Common Stock								144	I	By Alexa M. Anderson Separate Trust
Common Stock								144	I	By Cameron Taff Anderson Separate Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

	/s/ Kathryn W. Kyle Attorney-in-Fact for Kerrii B. Anderson	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)